Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25


Modified connectivity of vulnerable brain nodes in multiple sclerosis, their impact on cognition and their discriminative value.

Solana E, Martinez-Heras E, Casas-Roma J, Calvet L, Lopez-Soley E, Sepulveda M, Sola-Valls N, Montejo C, Blanco Y, Pulido-Valdeolivas I, Andorra M, Saiz A, Prados F, Llufriu S.

Sci Rep. 2019 Dec 27;9(1):20172. doi: 10.1038/s41598-019-56806-z.


Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors.

Sepúlveda M, Montejo C, Llufriu S, Sola-Valls N, Reyes D, Martinez-Lapiscina EH, Zubizarreta I, Pulido-Valdeolivas I, Martinez-Hernandez E, Ariño H, Baños N, Saiz A, Blanco Y.

Mult Scler Relat Disord. 2019 Oct 30;38:101483. doi: 10.1016/j.msard.2019.101483. [Epub ahead of print]


Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

Andorrà M, Alba-Arbalat S, Camos-Carreras A, Gabilondo I, Fraga-Pumar E, Torres-Torres R, Pulido-Valdeolivas I, Tercero-Uribe AI, Guerrero-Zamora AM, Ortiz-Perez S, Zubizarreta I, Sola-Valls N, Llufriu S, Sepulveda M, Martinez-Hernandez E, Armangue T, Blanco Y, Villoslada P, Sanchez-Dalmau B, Saiz A, Martinez-Lapiscina EH.

JAMA Neurol. 2019 Sep 30. doi: 10.1001/jamaneurol.2019.3283. [Epub ahead of print]


Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.

Sepulveda M, Delgado-García G, Blanco Y, Sola-Valls N, Martinez-Lapiscina EH, Armangué T, Montejo C, Pulido-Valdeolivas I, Martinez-Hernandez E, Ariño H, Escudero D, Ruiz-García R, Llufriu S, Dalmau J, Graus F, Saiz A.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 30;6(6). pii: e607. doi: 10.1212/NXI.0000000000000607. Print 2019 Nov.


MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.

Kotelnikova E, Kiani NA, Messinis D, Pertsovskaya I, Pliaka V, Bernardo-Faura M, Rinas M, Vila G, Zubizarreta I, Pulido-Valdeolivas I, Sakellaropoulos T, Faigle W, Silberberg G, Masso M, Stridh P, Behrens J, Olsson T, Martin R, Paul F, Alexopoulos LG, Saez-Rodriguez J, Tegner J, Villoslada P.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9671-9676. doi: 10.1073/pnas.1818347116. Epub 2019 Apr 19.


Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Zubizarreta I, Flórez-Grau G, Vila G, Cabezón R, España C, Andorra M, Saiz A, Llufriu S, Sepulveda M, Sola-Valls N, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Casanova B, Martinez Gines M, Tellez N, Oreja-Guevara C, Español M, Trias E, Cid J, Juan M, Lozano M, Blanco Y, Steinman L, Benitez-Ribas D, Villoslada P.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8463-8470. doi: 10.1073/pnas.1820039116. Epub 2019 Apr 8.


Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Villoslada P, Vila G, Colafrancesco V, Moreno B, Fernandez-Diez B, Vazquez R, Pertsovskaya I, Zubizarreta I, Pulido-Valdeolivas I, Messeguer J, Vendrell-Navarro G, Frade JM, López-Sánchez N, Teixido M, Giralt E, Masso M, Dugas JC, Leonoudakis D, Lariosa-Willingham KD, Steinman L, Messeguer A.

Neurotherapeutics. 2019 Jul;16(3):808-827. doi: 10.1007/s13311-019-00717-4.


Disease duration and disability in dysfeRlinopathy can be described by muscle imaging using heatmaps and random forests.

Gómez-Andrés D, Díaz J, Munell F, Sánchez-Montáñez Á, Pulido-Valdeolivas I, Suazo L, Garrido C, Quijano-Roy S, Bevilacqua JA.

Muscle Nerve. 2019 Apr;59(4):436-444. doi: 10.1002/mus.26403. Epub 2019 Jan 10.


Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.

Solà-Valls N, Vicente-Pascual M, Blanco Y, Solana E, Llufriu S, Martínez-Heras E, Martínez-Lapiscina EH, Sepúlveda M, Pulido-Valdeolivas I, Zubizarreta I, Saiz A.

Mult Scler Relat Disord. 2019 Jan;27:333-339. doi: 10.1016/j.msard.2018.11.018. Epub 2018 Nov 19.


Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis.

Solana E, Martinez-Heras E, Martinez-Lapiscina EH, Sepulveda M, Sola-Valls N, Bargalló N, Berenguer J, Blanco Y, Andorra M, Pulido-Valdeolivas I, Zubizarreta I, Saiz A, Llufriu S.

Neuroimage Clin. 2018 Jul 12;20:161-168. doi: 10.1016/j.nicl.2018.07.012. eCollection 2018.


Muscle imaging in laminopathies: Synthesis study identifies meaningful muscles for follow-up.

GóMez-Andrés D, Díaz-Manera J, Alejaldre A, Pulido-Valdeolivas I, GonzáLez-Mera L, Olivé M, Vilchez JJ, De Munain AL, Paradas C, Muelas N, SáNchez-MontáÑez Á, Alonso-Jimenez A, De la Banda MGG, Dabaj I, Bonne G, Munell F, Carlier RY, Quijano-Roy S.

Muscle Nerve. 2018 Dec;58(6):812-817. doi: 10.1002/mus.26312. Epub 2018 Nov 18.


Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine.

Sola-Valls N, Blanco Y, Sepúlveda M, Llufriu S, Martínez-Lapiscina EH, Zubizarreta I, Pulido-Valdeolivas I, Montejo C, Villoslada P, Saiz A.

Ther Adv Neurol Disord. 2018 Jun 10;11:1756286418780007. doi: 10.1177/1756286418780007. eCollection 2018.


Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.

Andorra M, Nakamura K, Lampert EJ, Pulido-Valdeolivas I, Zubizarreta I, Llufriu S, Martinez-Heras E, Sola-Valls N, Sepulveda M, Tercero-Uribe A, Blanco Y, Saiz A, Villoslada P, Martinez-Lapiscina EH.

JAMA Neurol. 2018 Oct 1;75(10):1246-1255. doi: 10.1001/jamaneurol.2018.1596.


Predictors of vision impairment in Multiple Sclerosis.

Sanchez-Dalmau B, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Zubizarreta I, Llufriu S, Blanco Y, Sola-Valls N, Sepulveda M, Guerrero A, Alba S, Andorra M, Camos A, Sanchez-Vela L, Alfonso V, Saiz A, Villoslada P.

PLoS One. 2018 Apr 17;13(4):e0195856. doi: 10.1371/journal.pone.0195856. eCollection 2018.


Gait phenotypes in paediatric hereditary spastic paraplegia revealed by dynamic time warping analysis and random forests.

Pulido-Valdeolivas I, Gómez-Andrés D, Martín-Gonzalo JA, Rodríguez-Andonaegui I, López-López J, Pascual-Pascual SI, Rausell E.

PLoS One. 2018 Mar 8;13(3):e0192345. doi: 10.1371/journal.pone.0192345. eCollection 2018.


Dynamics and heterogeneity of brain damage in multiple sclerosis.

Kotelnikova E, Kiani NA, Abad E, Martinez-Lapiscina EH, Andorra M, Zubizarreta I, Pulido-Valdeolivas I, Pertsovskaya I, Alexopoulos LG, Olsson T, Martin R, Paul F, Tegnér J, Garcia-Ojalvo J, Villoslada P.

PLoS Comput Biol. 2017 Oct 26;13(10):e1005757. doi: 10.1371/journal.pcbi.1005757. eCollection 2017 Oct.


Early retinal atrophy predicts long-term visual impairment after acute optic neuritis.

Sanchez-Dalmau B, Martinez-Lapiscina EH, Torres-Torres R, Ortiz-Perez S, Zubizarreta I, Pulido-Valdeolivas IV, Alba-Arbalat S, Guerrero-Zamora A, Calbet D, Villoslada P.

Mult Scler. 2018 Aug;24(9):1196-1204. doi: 10.1177/1352458517718628. Epub 2017 Jul 3.


Metabolomic signatures associated with disease severity in multiple sclerosis.

Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321. doi: 10.1212/NXI.0000000000000321. eCollection 2017 Mar.


Patterns of motor signs in spinocerebellar ataxia type 3 at the start of follow-up in a reference unit.

Pulido-Valdeolivas I, Gómez-Andrés D, Sanz-Gallego I, Rausell E, Arpa J.

Cerebellum Ataxias. 2016 Feb 23;3:4. doi: 10.1186/s40673-016-0042-6. eCollection 2016.


Putamina involvement in Wernicke encephalopathy induced by Janus Kinase 2 inhibitor.

Rodríguez-Pardo J, Puertas-Muñoz I, Martínez-Sánchez P, Díaz de Terán J, Pulido-Valdeolivas I, Fuentes B.

Clin Neuropharmacol. 2015 May-Jun;38(3):117-8. doi: 10.1097/WNF.0000000000000083.


Substantia nigra echogenicity in hereditary ataxias with and without nigrostriatal pathology: a pilot study.

Martínez-Sánchez P, Cazorla-García R, Sanz-Gallego I, Correas-Callero E, Pulido-Valdeolivas I, Arpa J.

Cerebellum. 2015 Jun;14(3):240-6. doi: 10.1007/s12311-014-0642-8.


Abnormal motor phenotype at adult stages in mice lacking type 2 deiodinase.

Bárez-López S, Bosch-García D, Gómez-Andrés D, Pulido-Valdeolivas I, Montero-Pedrazuela A, Obregon MJ, Guadaño-Ferraz A.

PLoS One. 2014 Aug 1;9(8):e103857. doi: 10.1371/journal.pone.0103857. eCollection 2014.


[External evaluation of gait and functional changes after a single-session multiple myofibrotenotomy in school-aged children with spastic diplegia].

Gómez-Andrés D, Pulido-Valdeolivas I, Martín-Gonzalo JA, López-López J, Martínez-Caballero I, Gómez-Barrena E, Rausell E.

Rev Neurol. 2014 Mar 16;58(6):247-54. Spanish.


'SARAgraph': a proposed graphic system for representing ataxia progression.

Pulido-Valdeolivas I, Gómez-Andrés D, Sanz-Gallego I, Arpa-Gutiérrez J.

Neurologia. 2015 Jul-Aug;30(6):387-8. doi: 10.1016/j.nrl.2013.08.003. Epub 2014 Feb 12. English, Spanish. No abstract available.


Gait parameters in a reference sample of healthy Spanish schoolchildren: multivariate descriptive statistics and asymmetries observed in left and right cycles.

Pulido-Valdeolivas I, Gómez-Andrés D, Martín-Gonzalo JA, López-López J, Gómez-Barrena E, Sánchez Hernández JJ, Rausell E.

Neurologia. 2013 Apr;28(3):145-52. doi: 10.1016/j.nrl.2012.04.006. Epub 2012 Jun 14. English, Spanish.

Supplemental Content

Loading ...
Support Center